TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Swedish Orphan Biovitrum International AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 2,150 | 2,294 | 3,383 |
Financial expenses | 8,834 | 9,542 | 9,906 |
Earnings before taxes | -8,581 | -14,578 | -8,782 |
EBITDA | 118 | -2,987 | 3,243 |
Total assets | 539,878 | 565,865 | 563,817 |
Current assets | 37,941 | 18,535 | 4,938 |
Current liabilities | 1,339 | 1,588 | 5,287 |
Equity capital | 110,937 | 105,281 | 91,402 |
- share capital | 56 | 61 | 62 |
Employees (average) | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 20.5% | 18.6% | 16.2% |
Turnover per employee | |||
Profit as a percentage of turnover | -399.1% | -635.5% | -259.6% |
Return on assets (ROA) | 0.0% | -0.9% | 0.2% |
Current ratio | 2833.5% | 1167.2% | 93.4% |
Return on equity (ROE) | -7.7% | -13.8% | -9.6% |
Change turnover | 42 | -1,027 | -1,035 |
Change turnover % | 2% | -31% | -23% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.